DermDash: Vitiligo Spotlight: A Closer Look at JAK Inhibitors: An Online Actvity

Released on

December 3, 2025

Earn up to

0.25 AMA PRA Category 1 Credit™

This 15-minute DermDash highlights practical, real-world pearls for incorporating JAK inhibitors into the management of patients with vitiligo. Learners will review emerging data, patient selection considerations, and strategies to optimize long-term outcomes and durability of repigmentation in clinical practice.

FC25: Vitiligo Derm Dash: Exploring Treatment Advances and Optimizing Patient Care: An Online Activity

This activity is supported by an educational grant from Incyte.

DermDash: Vitiligo Spotlight: A Closer Look at JAK Inhibitors: An Online Actvity

About

Availability

Learning Objectives

Intended Audience

Faculty

Accreditation Statement

Credit Designation Statement

Disclosures